Found: 12
Select item for more details and to access through your institution.
Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 8, p. 1040, doi. 10.1111/apt.16866
- By:
- Publication type:
- Article
Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 10, p. 2803, doi. 10.1111/jgh.15551
- By:
- Publication type:
- Article
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 6, p. 2635, doi. 10.1007/s10620-023-07956-8
- By:
- Publication type:
- Article
Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 6, p. 2658, doi. 10.1007/s10620-023-07825-4
- By:
- Publication type:
- Article
Introduction to the 101st Volume of the UTMJ Issue on Longevity.
- Published in:
- University of Toronto Medical Journal, 2024, v. 101, n. 2, p. 6
- By:
- Publication type:
- Article
Combined Histological and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared with Endoscopic Improvement Alone in Ulcerative Colitis: A Post hoc Analysis of the VARSITY study.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 7, p. 1114, doi. 10.1093/ecco-jcc/jjad033
- By:
- Publication type:
- Article
Beyond the White Pill: Advocating for Racial Diversity in IBD Trials.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 3, p. 459, doi. 10.1093/ecco-jcc/jjac134
- By:
- Publication type:
- Article
Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD].
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 7, p. 1011, doi. 10.1093/ecco-jcc/jjac018
- By:
- Publication type:
- Article
Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 10, p. 1649, doi. 10.1093/ecco-jcc/jjab045
- By:
- Publication type:
- Article
End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 7, p. 1114, doi. 10.1093/ecco-jcc/jjaa242
- By:
- Publication type:
- Article
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 3, p. 462, doi. 10.1093/ecco-jcc/jjaa189
- By:
- Publication type:
- Article
Upfront cytoreductive nephrectomy vs. upfront systemic therapy in metastatic kidney cancer.
- Published in:
- Canadian Urological Association Journal, 2019, v. 13, n. 11, p. E377, doi. 10.5489/cuaj.5666
- By:
- Publication type:
- Article